Joel S. Marcus, JD, CPA, is Executive Chairman and Founder of Alexandria Real Estate Equities, Inc. (NYSE: ARE), the REIT that pioneered life science real estate from a specialty niche to a mainstream asset class. Today, it is the preeminent and longest-tenured owner, operator, and developer uniquely focused on collaborative life science, agtech, and technology campuses in AAA innovation clusters. Since co-founding the company in 1994, as a garage startup with $19 million in Series A capital and a mission to advance human health, he has led the remarkable growth of Alexandria into an S&P 500 company that as of December 31, 2021, has a total market capitalization of $44.0 billion, and a total equity capitalization of $35.2 billion, ranking it among the top 10% of all publicly traded U.S. REITs by equity capitalization. Alexandria, which celebrates its 25th anniversary as a New York Stock Exchange listed company in May 2022, has a total shareholder return exceeding 2,500% as of December 31, 2021.

Mr. Marcus also founded and continues to lead Alexandria Venture Investments, the company’s strategic venture capital platform. Since its inception in 1996, it has strategically invested in disruptive life science, agrifoodtech, climate innovation, and technology companies advancing transformative new modalities and platforms to meaningfully improve human health. With nearly $2 billion in carrying value, Alexandria Venture Investments has been recognized by Silicon Valley Bank as the #1 most active corporate venture capital investor in biopharma by new deal volume for five consecutive years and by AgFunder as one of the top five most active U.S. agrifoodtech investors for the second consecutive year.

Prior to co-founding Alexandria, Mr. Marcus had an extensive legal career specializing in corporate finance and capital markets, venture capital, and mergers and acquisitions with special expertise in the biopharmaceutical industry. He serves on the boards of directors of several public and private companies, including Applied Therapeutics, Inc. (NASDAQ: APLT), Frequency Therapeutics, Inc. (NASDAQ: FREQ), Intra-Cellular Therapies, Inc. (NASDAQ: ITCI), and MeiraGTx Holdings plc (NASDAQ: MGTX). In addition to the FNIH, Mr. Marcus serves on the boards of several non-profit organizations, including the Emily Krzyzewski Center, the National Medal of Honor Museum, the Navy SEAL Foundation, the Parker Institute for Cancer Immunotherapy, and the 9/11 Memorial & Museum. He received his undergraduate and Juris Doctor degrees from the University of California, Los Angeles.